Total Payments
$3,127
2024 Payments
$633.39
Companies
42
Transactions
191
Medicare Patients
772
Medicare Billing
$32,493
Payment Breakdown by Category
Food & Beverage$3,127 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,127 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $411.58 | 26 | $0 (2024) |
| ABBVIE INC. | $242.63 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $210.82 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $208.34 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $180.43 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $167.90 | 12 | $0 (2022) |
| Novo Nordisk Inc | $153.00 | 10 | $0 (2024) |
| Abbott Laboratories | $137.53 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $115.59 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.93 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $633.39 | 36 | Lilly USA, LLC ($160.06) |
| 2023 | $727.92 | 38 | Lilly USA, LLC ($151.11) |
| 2022 | $371.19 | 21 | AstraZeneca Pharmaceuticals LP ($59.44) |
| 2020 | $94.99 | 6 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39.64) |
| 2019 | $412.33 | 27 | Merck Sharp & Dohme Corporation ($67.74) |
| 2018 | $475.09 | 33 | Merck Sharp & Dohme Corporation ($67.07) |
| 2017 | $412.54 | 30 | AstraZeneca Pharmaceuticals LP ($69.56) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Cranial Orthotic | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardio-renal | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Oncology | ||||||
| 07/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 05/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardio-renal | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 04/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 52 | 74 | $10,770 | $4,234 |
| 2022 | 3 | 64 | 97 | $12,267 | $4,299 |
| 2021 | 11 | 300 | 347 | $27,379 | $10,870 |
| 2020 | 12 | 356 | 439 | $41,078 | $13,089 |
Total Patients
772
Total Services
957
Medicare Billing
$32,493
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 31 | $6,313 | $2,316 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 26 | $3,709 | $1,596 | 43.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 17 | $748.00 | $322.32 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 41 | $8,282 | $2,823 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 27 | $3,753 | $1,390 | 37.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 29 | $232.00 | $86.07 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 73 | $13,870 | $3,856 | 27.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $3,940 | $2,711 | 68.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 42 | $5,460 | $1,521 | 27.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 22 | 22 | $902.00 | $745.35 | 82.6% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 16 | 16 | $656.00 | $656.00 | 100.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 22 | 22 | $902.00 | $573.42 | 63.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 21 | 21 | $630.00 | $406.14 | 64.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 58 | 71 | $568.00 | $207.90 | 36.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $451.00 | $192.83 | 42.8% |
| 91301 | Sarscov2 vac 100mcg/0.5ml im | Office | 2021 | 20 | 33 | $0.33 | $0.33 | 100.0% |
| 91306 | Coronavirus vaccine 7 | Office | 2021 | 16 | 16 | $0.16 | $0.16 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 84 | 122 | $23,012 | $5,852 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 23 | 23 | $4,531 | $2,724 | 60.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 44 | $5,675 | $1,145 | 20.2% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $759.00 | $670.78 | 88.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 35 | 35 | $1,435 | $599.56 | 41.8% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 11 | 12 | $2,220 | $490.96 | 22.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 26 | 26 | $780.00 | $484.46 | 62.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 24 | 24 | $672.00 | $468.99 | 69.8% |
About Dr. Kyle Waugh, MD
Dr. Kyle Waugh, MD is a Family Medicine healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982693149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Waugh, MD has received a total of $3,127 in payments from pharmaceutical and medical device companies, with $633.39 received in 2024. These payments were reported across 191 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,127).
As a Medicare-enrolled provider, Waugh has provided services to 772 Medicare beneficiaries, totaling 957 services with total Medicare billing of $32,493. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Greeley, CO
- Active Since 10/19/2005
- Last Updated 04/09/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982693149
Products in Payments
- VRAYLAR (Drug) $219.39
- JARDIANCE (Drug) $208.75
- FARXIGA (Drug) $185.34
- Kerendia (Drug) $180.43
- MOUNJARO (Drug) $150.90
- JANUVIA (Drug) $112.22
- TRULICITY (Drug) $100.41
- Cologuard Collection Kit (Device) $95.15
- BEXSERO (Biological) $92.00
- FREESTYLE LIBRE 3 (Device) $88.37
- NURTEC ODT (Drug) $86.90
- AREXVY (Drug) $75.76
- Prolia (Biological) $75.02
- XIFAXAN (Drug) $74.18
- Trintellix (Drug) $73.27
- Rybelsus (Drug) $68.78
- XARELTO (Drug) $65.60
- Myrbetriq (Drug) $62.86
- LEQVIO (Drug) $59.57
- ENTRESTO (Drug) $56.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greeley
Joy Ruff, M.d, M.D
Family Medicine — Payments: $44,700
Family Medicine $44,700
Dr. Chima Nwizu, Md, MD
Family Medicine — Payments: $6,387
Family Medicine $6,387
Dr. Gregory Denzel, Do, DO
Family Medicine — Payments: $5,085
Family Medicine $5,085
Dr. Donald Wilson, Md, MD
Family Medicine — Payments: $4,831
Family Medicine $4,831
Dr. Robert Haskins, Md, MD
Family Medicine — Payments: $3,179
Family Medicine $3,179
Erin Morley, M.d, M.D
Family Medicine — Payments: $2,848
Family Medicine $2,848